➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Harvard Business School
Express Scripts
Baxter
Medtronic

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

Patent: 7,736,886

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,736,886
Title:Recombination systems and methods for eliminating nucleic acid sequences from the genome of eukaryotic organisms
Abstract: The invention relates to recombination systems and methods for eliminating nucleic acid sequences from the chromosomal DNA of eukaryotic organisms, and to transgenic organisms--preferably plants--which comprise these systems or were generated using these methods.
Inventor(s): Puchta; Holger (Karlsruhe, DE), Biesgen; Christian (Quedlinburg, DE)
Assignee: SunGene GmbH & Co. KGaA and Institut f. Pflanzengenetik u. Kulturpflanzenforschung (DE) N/A (N/A)
Application Number:10/750,891
Patent Claims:see list of patent claims

Details for Patent 7,736,886

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial SunGene GmbH & Co. KGaA and Institut f. Pflanzengenetik u. Kulturpflanzenforschung (DE) N/A (N/A) 2021-07-04 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial SunGene GmbH & Co. KGaA and Institut f. Pflanzengenetik u. Kulturpflanzenforschung (DE) N/A (N/A) 2021-07-04 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial SunGene GmbH & Co. KGaA and Institut f. Pflanzengenetik u. Kulturpflanzenforschung (DE) N/A (N/A) 2021-07-04 RX search
Aimmune Therapeutics PALFORZIA peanut KIT 125696 1 2020-01-31   Start Trial SunGene GmbH & Co. KGaA and Institut f. Pflanzengenetik u. Kulturpflanzenforschung (DE) N/A (N/A) 2021-07-04 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Mallinckrodt
Moodys
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.